{
  "report_rows": [
    {
      "kpi": "U.S. comparable sales growth",
      "prediction": "BEAT",
      "answer": "pred ~6.8% vs. cons 6.0%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.67 vs. cons $0.65",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Consolidated operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~12.4% vs. cons 12.33%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.40 midpoint vs. cons $2.40 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Global comparable-sales growth guidance",
      "prediction": "BETTER",
      "answer": "guide ~5.5% vs. cons 5.4% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Consolidated operating-margin growth guidance",
      "prediction": "LOWER",
      "answer": "guide ~+20 bps YoY vs. cons +30 bps YoY (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 2.7,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.8,
  "day5_path": "FADE",
  "day5_rationale": "Day-5 residual ~+0.8% vs. day-1 ~+2.7%: transaction-led comps and a modest EPS beat support the initial reaction, but unchanged FY2026 EPS guidance and ~10 bps of margin-guide shortfall imply limited Q4/FY2027 estimate upside, causing revisions to lag the headline beat.",
  "day5_confidence": "MEDIUM"
}